We tested the hypothesis that CCL21/CCR7 increases the migration potentiality of pancreatic cancer stem-like cells as well as promoting survival, by CCR7 knockdown with small interfering (si) RNA. Here, CCL21 is linked to familial pancreatic carcinoma.